{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:08:33Z","timestamp":1791284913758,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ebiom.2024.105260","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T18:51:28Z","timestamp":1722019888000},"page":"105260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["A susceptibility gene signature for ERBB2-driven mammary tumour development and metastasis in collaborative cross mice"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3152-1285","authenticated-orcid":false,"given":"Hui","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Blanco-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Garc\u00eda-Sancha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Corchado-Cobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Jes\u00fas","family":"P\u00e9rez-Baena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Jim\u00e9nez-Navas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie L.","family":"Inman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine M.","family":"Snijders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Threadgill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Balmain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3773-6818","authenticated-orcid":false,"given":"Hang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Perez-Losada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9320-6021","authenticated-orcid":false,"given":"Jian-Hua","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4785","key":"10.1016\/j.ebiom.2024.105260_bib1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"issue":"4905","key":"10.1016\/j.ebiom.2024.105260_bib2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.2470152","article-title":"Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer","volume":"244","author":"Slamon","year":"1989","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105260_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0959-8049(00)00395-6","article-title":"c-erbB-2 positivity is a factor for poor prognosis in breast cancer and poor response to hormonal or chemotherapy treatment in advanced disease","volume":"37","author":"Jukkola","year":"2001","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105260_bib4","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ijc.2910490504","article-title":"Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer","volume":"49","author":"Kallioniemi","year":"1991","journal-title":"Int J Cancer"},{"issue":"18","key":"10.1016\/j.ebiom.2024.105260_bib5","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1056\/NEJM199405053301802","article-title":"c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer","volume":"330","author":"Muss","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105260_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/stem.160413","article-title":"The HER-2\/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy","volume":"16","author":"Ross","year":"1998","journal-title":"Stem Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105260_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/GCO.0b013e3283414e87","article-title":"Human epidermal growth factor receptor-2-positive breast cancer: current management of early, advanced, and recurrent disease","volume":"23","author":"Callahan","year":"2011","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"18","key":"10.1016\/j.ebiom.2024.105260_bib8","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.ejca.2008.09.013","article-title":"Her2-positive breast cancer: herceptin and beyond","volume":"44","author":"Dean-Colomb","year":"2008","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105260_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1586\/era.10.226","article-title":"HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies","volume":"11","author":"Gajria","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105260_bib10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4161\/cbt.11.9.15045","article-title":"Resistance to HER2-directed antibodies and tyrosine kinase inhibitors: mechanisms and clinical implications","volume":"11","author":"Garrett","year":"2011","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105260_bib11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1517\/14656566.2011.525218","article-title":"Hitting multiple targets in HER2-positive breast cancer: proof of principle or therapeutic opportunity?","volume":"12","author":"Geuna","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ebiom.2024.105260_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13059-015-0599-z","article-title":"Unraveling heterogeneous susceptibility and the evolution of breast cancer using a systems biology approach","volume":"16","author":"Castellanos-Martin","year":"2015","journal-title":"Genome Biol"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105260_bib13","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ng1104-1133","article-title":"The collaborative cross, a community resource for the genetic analysis of complex traits","volume":"36","author":"Churchill","year":"2004","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105260_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00335-001-4001-y","article-title":"Genetic dissection of complex and quantitative traits: from fantasy to reality via a community effort","volume":"13","author":"Threadgill","year":"2002","journal-title":"Mamm Genome"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105260_bib15","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1534\/genetics.104.035709","article-title":"Quantitative trait locus analysis using recombinant inbred intercrosses: theoretical and empirical considerations","volume":"170","author":"Zou","year":"2005","journal-title":"Genetics"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105260_bib16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1186\/s12864-021-07890-x","article-title":"Genetic mapping of novel modifiers for Apc(Min) induced intestinal polyps' development using the genetic architecture power of the collaborative cross mice","volume":"22","author":"Dorman","year":"2021","journal-title":"BMC Genomics"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105260_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256370","article-title":"Host genetic diversity drives variable central nervous system lesion distribution in chronic phase of Theiler's Murine Encephalomyelitis Virus (TMEV) infection","volume":"16","author":"Lawley","year":"2021","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105260_bib18","doi-asserted-by":"crossref","first-page":"67011","DOI":"10.1289\/EHP5105","article-title":"Using collaborative cross mouse population to fill data gaps in risk assessment: a case study of population-based analysis of toxicokinetics and kidney toxicodynamics of tetrachloroethylene","volume":"127","author":"Luo","year":"2019","journal-title":"Environ Health Perspect"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105260_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40168-020-00817-w","article-title":"Genetic and metabolic links between the murine microbiome and memory","volume":"8","author":"Mao","year":"2020","journal-title":"Microbiome"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105260_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ame2.12151","article-title":"Studying host genetic background effects on multimorbidity of intestinal cancer development, type 2 diabetes and obesity in response to oral bacterial infection and high-fat diet using the collaborative cross (CC) lines","volume":"4","author":"Milhem","year":"2021","journal-title":"Animal Model Exp Med"},{"key":"10.1016\/j.ebiom.2024.105260_bib21","doi-asserted-by":"crossref","first-page":"152902","DOI":"10.1016\/j.tox.2021.152902","article-title":"Human-relevant mechanisms and risk factors for TAK-875-Induced liver injury identified via a gene pathway-based approach in collaborative cross mice","volume":"461","author":"Mosedale","year":"2021","journal-title":"Toxicology"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105260_bib22","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.chom.2019.03.009","article-title":"The collaborative cross: a systems genetics resource for studying host-pathogen interactions","volume":"25","author":"Noll","year":"2019","journal-title":"Cell Host Microbe"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105260_bib23","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1136\/gutjnl-2018-316691","article-title":"Diverse tumour susceptibility in collaborative cross mice: identification of a new mouse model for human gastric tumourigenesis","volume":"68","author":"Wang","year":"2019","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105260_bib24","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1534\/g3.119.400232","article-title":"Doxorubicin-Induced cardiotoxicity in collaborative cross (CC) mice recapitulates individual cardiotoxicity in humans","volume":"9","author":"Zeiss","year":"2019","journal-title":"G3 (Bethesda)"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105260_bib25","doi-asserted-by":"crossref","first-page":"13285","DOI":"10.1038\/s41598-021-92702-1","article-title":"Genetic background influences the effect of thirdhand smoke exposure on anxiety and memory in collaborative cross mice","volume":"11","author":"He","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105260_bib26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41598-020-79538-x","article-title":"Gut microbiome partially mediates and coordinates the effects of genetics on anxiety-like behavior in collaborative cross mice","volume":"11","author":"Jin","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2024.105260_bib27","doi-asserted-by":"crossref","first-page":"16221","DOI":"10.1038\/nmicrobiol.2016.221","article-title":"Influence of early life exposure, host genetics and diet on the mouse gut microbiome and metabolome","volume":"2","author":"Snijders","year":"2016","journal-title":"Nat Microbiol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105260_bib28","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00204-021-02972-x","article-title":"Host genetics and gut microbiota cooperatively contribute to azoxymethane-induced acute toxicity in collaborative cross mice","volume":"95","author":"Zhong","year":"2021","journal-title":"Arch Toxicol"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105260_bib29","doi-asserted-by":"crossref","first-page":"107587","DOI":"10.1016\/j.celrep.2020.107587","article-title":"Complex genetic architecture underlies regulation of influenza-A-virus-specific antibody responses in the collaborative cross","volume":"31","author":"Noll","year":"2020","journal-title":"Cell Rep"},{"issue":"W1","key":"10.1016\/j.ebiom.2024.105260_bib30","doi-asserted-by":"crossref","first-page":"W130","DOI":"10.1093\/nar\/gkx356","article-title":"WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105260_bib31","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","article-title":"Supervised risk predictor of breast cancer based on intrinsic subtypes","volume":"27","author":"Parker","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105260_bib32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"269","key":"10.1016\/j.ebiom.2024.105260_bib33","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"issue":"D1","key":"10.1016\/j.ebiom.2024.105260_bib34","doi-asserted-by":"crossref","first-page":"D977","DOI":"10.1093\/nar\/gkac1010","article-title":"The NHGRI-EBI GWAS Catalog: knowledgebase and deposition resource","volume":"51","author":"Sollis","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105260_bib35","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.3390\/ijms22052622","article-title":"TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues","volume":"22","author":"Bartha","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105260_bib36","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ccell.2022.05.005","article-title":"Redefining breast cancer subtypes to guide treatment prioritization and maximize response: predictive biomarkers across 10 cancer therapies","volume":"40","author":"Wolf","year":"2022","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105260_bib37","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1158\/2159-8290.CD-18-1175","article-title":"Challenges for the clinical development of PI3K inhibitors: strategies to improve their impact in solid tumors","volume":"9","author":"Hanker","year":"2019","journal-title":"Cancer Discov"},{"issue":"10087","key":"10.1016\/j.ebiom.2024.105260_bib38","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/S0140-6736(16)32417-5","article-title":"HER2-positive breast cancer","volume":"389","author":"Loibl","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2024.105260_bib39","first-page":"9386477","article-title":"Association of PTPRT mutations with cancer metastasis in multiple cancer types","volume":"2022","author":"Chen","year":"2022","journal-title":"Biomed Res Int"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105260_bib40","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3390\/cancers10090314","article-title":"PTPRT and PTPRD deleterious mutations and deletion predict bevacizumab resistance in metastatic colorectal cancer patients","volume":"10","author":"Hsu","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105260_bib41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-0463.2007.apm_554.x","article-title":"Mutational analysis of PTPRT phosphatase domains in common human cancers","volume":"115","author":"Lee","year":"2007","journal-title":"APMIS"},{"key":"10.1016\/j.ebiom.2024.105260_bib42","first-page":"3301402","article-title":"PTPRT could be a treatment predictive and prognostic biomarker for breast cancer","volume":"2021","author":"Li","year":"2021","journal-title":"Biomed Res Int"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105260_bib43","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1073\/pnas.1319551111","article-title":"Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer","volume":"111","author":"Lui","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105260_bib44","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1042\/BSR20100134","article-title":"Tumour suppressor function of protein tyrosine phosphatase receptor-T","volume":"31","author":"Scott","year":"2011","journal-title":"Biosci Rep"},{"issue":"6-7","key":"10.1016\/j.ebiom.2024.105260_bib45","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1080\/15592294.2019.1676597","article-title":"PTPRT epigenetic silencing defines lung cancer with STAT3 activation and can direct STAT3 targeted therapies","volume":"15","author":"Sen","year":"2020","journal-title":"Epigenetics"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105260_bib46","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.45836","article-title":"Whole-exome sequencing among Chinese patients with hereditary diffuse gastric cancer","volume":"5","author":"Liu","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"7403","key":"10.1016\/j.ebiom.2024.105260_bib47","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105260_bib48","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1200\/JCO.2014.55.6894","volume":"33","author":"Sestak","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105260_bib49","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa1602253","article-title":"70-Gene signature as an aid to treatment decisions in early-stage breast cancer","volume":"375","author":"Cardoso","year":"2016","journal-title":"N\u00a0Engl J Med"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424002962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424002962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T23:36:54Z","timestamp":1724283414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424002962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":49,"alternative-id":["S2352396424002962"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105260","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A susceptibility gene signature for ERBB2-driven mammary tumour development and metastasis in collaborative cross mice","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105260","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105260"}}